Chandelier | The Winner - 30159 | The Winner,Short Interval Blocks for Endurance Athletes- Part1,Efficacy | ZEJULA (niraparib) for HCPs,Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy | British Journal of Cancer,Advanced or Recurrent Ovarian Cancer Resource Library – LYNPARZA® (olaparib)